Gain Therapeutics (GANX) Intangibles (2021 - 2025)
Historic Intangibles for Gain Therapeutics (GANX) over the last 5 years, with Q3 2025 value amounting to $114607.0.
- Gain Therapeutics' Intangibles fell 2665.43% to $114607.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $114607.0, marking a year-over-year decrease of 2665.43%. This contributed to the annual value of $134268.0 for FY2024, which is 3056.6% down from last year.
- Latest data reveals that Gain Therapeutics reported Intangibles of $114607.0 as of Q3 2025, which was down 2665.43% from $127857.0 recorded in Q2 2025.
- Gain Therapeutics' Intangibles' 5-year high stood at $213967.0 during Q4 2022, with a 5-year trough of $114607.0 in Q3 2025.
- In the last 5 years, Gain Therapeutics' Intangibles had a median value of $189242.0 in 2023 and averaged $174391.0.
- Per our database at Business Quant, Gain Therapeutics' Intangibles soared by 560.59% in 2022 and then plummeted by 3056.6% in 2024.
- Gain Therapeutics' Intangibles (Quarter) stood at $202609.0 in 2021, then increased by 5.61% to $213967.0 in 2022, then decreased by 9.62% to $193375.0 in 2023, then crashed by 30.57% to $134268.0 in 2024, then dropped by 14.64% to $114607.0 in 2025.
- Its Intangibles was $114607.0 in Q3 2025, compared to $127857.0 in Q2 2025 and $126291.0 in Q1 2025.